PointState Capital’s Insmed INSM Stock Holding History

PointState Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-226,000	Closed	-$5.09M	–	183
2018 Q1	$5.09M	Buy	+226,000	New	+$5.95M	0.06%	112
2014 Q1	–	Sell	-200,000	Closed	-$3.4M	–	138
2013 Q4	$3.4M	Buy	+200,000	New	+$3.06M	0.04%	123
2013 Q3	–	Sell	-250,000	Closed	-$2.99M	–	146
2013 Q2	$2.99M	Buy	+250,000	New	+$2.56M	0.05%	118

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

PointState Capital's INSM Position: Q2 2018 in Review

PointState Capital sold out of Insmed (INSM) in Q2 2018, closing a stake of 226,000 shares — an estimated $5.09M sold.

PointState Capital first reported a position in INSM in Q2 2013 and held it in 3 quarters. The position peaked at $5.09M in Q1 2018. 127 funds tracked by Wall St. Rank hold INSM as of Q2 2018.

PointState Capital reported no remaining Insmed position as of Q2 2018 after selling out during the quarter.
PointState Capital sold 226,000 Insmed shares in Q2 2018, an estimated $5.09M.
PointState Capital first reported a position in Insmed in Q2 2013 and held it in 3 quarters.
PointState Capital's Insmed position peaked at $5.09M in Q1 2018.
127 funds tracked by Wall St. Rank held Insmed as of Q2 2018.

Based on PointState Capital's 13F filing for Q2 2018, filed 14 Aug 2018.